RespireRx Phamaceuticals
A biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea. Learn more
Launch date
Employees
Market cap
€429k
Enterprise valuation
€4m (Public information from Sep 2024)
Share price
$0.0011 RSPI
Irvine California (HQ)
Authorizing premium user...